Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CVE✓SelectedUSD · CVEMRNA vs CVE performance historyLatest closeAs of+1.29%11/19
Stock and ETF performance explorer

MRNA vs CVE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+724.4%
CVE return
+52.8%
Excess return
+671.5%
Maximum drawdown
-34.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioCVEExcessAlpha
1D+1.3%-0.3%+1.5%+1.2%
7D-13.8%-6.0%-7.9%-14.8%
30D-17.7%-18.1%+0.5%-20.3%
3M+14.3%-16.0%+30.3%+11.8%
6M+336.0%-13.7%+349.7%+344.3%
YTD+575.9%+63.2%+512.7%+419.4%
1Y+724.4%+51.3%+673.0%+547.2%
All+724.4%+52.8%+671.5%+547.2%

Cumulative growth

Daily Returns

Daily percentage return beside CVE.

Daily Out/Under-Performance

Portfolio return minus CVE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling